Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Bladder Carcinoma	NCIT_C4912	[A carcinoma arising from the bladder epithelium. Approximately 90% of the bladder carcinomas are transitional cell carcinomas. The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.]
Recurrent Small Intestinal Carcinoma	NCIT_C7894	[The reemergence of small intestine carcinoma after a period of remission.]
Stage 0 Bladder Cancer AJCC v6 and v7	NCIT_C7895	[Stage 0 includes: 0a (Ta, N0, M0); 0is (Tis, N0, M0). Ta: Noninvasive papillary carcinoma. Tis: Carcinoma in situ: "flat tumor". N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.)]
Stage I Bladder Cancer AJCC v6 and v7	NCIT_C7896	[Stage I includes: T1, N0, M0. T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)]
Stage II Bladder Cancer AJCC v6 and v7	NCIT_C7897	[Stage II includes: (T2a, N0, M0); (T2b, N0, M0). T2a: Tumor invades superficial muscle (inner half). T2b: Tumor invades deep muscle (outer half). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.)]
Unresectable Gallbladder Carcinoma	NCIT_C7890	[A carcinoma that arises from the gallbladder and it is not amenable to surgical resection.]
Unresectable Digestive System Carcinoma	NCIT_C155903	[Digestive system carcinoma that is not amenable to surgical resection.]
Localized Extrahepatic Bile Duct Carcinoma	NCIT_C7891	[A carcinoma that arises from the extrahepatic bile ducts and it has not spread to other anatomic sites.]
Unresectable Extrahepatic Bile Duct Carcinoma	NCIT_C7892	[Extrahepatic bile duct carcinoma that is not amenable to surgical removal.]
Recurrent Extrahepatic Bile Duct Carcinoma	NCIT_C7893	[The reemergence of an extrahepatic bile duct carcinoma after a period of remission.]
Recurrent Bile Duct Carcinoma	NCIT_C153360	[The reemergence of bile duct carcinoma after a period of remission.]
Performed Lesion Description Measurable Indicator	NCIT_C93927	[Specifies whether a lesion or site of disease is measurable.]
Measurable Indicator	NCIT_C93593	[Specifies whether an entity is measurable.]
Performed Medical History Result End Relative To Reference Code	NCIT_C93928	[A coded value specifying the end of the medical history event with respect to the sponsor-defined reference period.]
Performed Medical History Result Occurrence Date Range	NCIT_C93929	[The date and time span in which the medical history event began and ended.]
Occurrence Date Range	NCIT_C93608	[The date and time span in which the event began and ended.]
Phenoxymethylpenicillin	NCIT_C29360
Phentermine Hydrochloride	NCIT_C29361	[The hydrochloride salt form of phentermine, a sympathomimetic amine with central nervous system (CNS) stimulant and appetite depressant properties. Phentermine hydrochloride stimulates the release of norepinephrine and dopamine from nerve endings and blocks the reuptake of these monoamines at the neuronal junctions, resulting in CNS stimulation and metabolic effects, including appetite-suppression, decreased gastric acid secretion and increased blood pressure.]
Phenylephrine/Phenylpropanolamine/Guaifenesin	NCIT_C29362	[A combination preparation containing phenylephrine, phenylpropanolamine and guaifenesin with decongestant and expectorant activities. Phenylephrine and phenylpropanolamine, direct-acting sympathicomimetic amines, activate alpha-adrenergic receptors in the nasal mucosa thereby causing vasoconstriction, reduces swelling of nasal mucous membranes and decreasing nasal and sinus congestion. Phenylpropanolamine also releases norepinephrine from its storage sites resulting in the effects already described. Guaifenesin increases respiratory tract mucus secretions and reduces the viscosity of mucus secretion by reducing adhesiveness and surface tension as well as increasing hydration of mucus, thereby increasing the efficiency of removing accumulated secretions from the upper and lower airways and making cough more productive.]
Cough and Cold Preparation	NCIT_C29630	[Synthetic compounds or mixtures that usually contain a combination of any of the following agents depending on the symptoms that need to be treated: an antitussive, a decongestant, an antihistamine, an analgesic antipyretic, an expectorant and/or an anticholinergic agent. A cough and cold preparation is usually administered orally to relieve symptoms of the cold, flu or allergy, such as cough, congestion, itchy, watery eyes, runny nose, sore throat and fever.]